← Open Payments lookup

MARCOS YASSA: Open Payments

NPI 1952899742 · NEW BALTIMORE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,228 in 47 payments from 11 companies in 2025. Trend: 2023 $1,381 · 2024 $1,452 · 2025 $1,228

Food & beverage: $1,228
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.3$250
Alkermes, Inc.10$243
Otsuka America Pharmaceutical, Inc.5$206
ABBVIE INC.12$148
Indivior Inc.6$132
Braeburn Inc.3$73
Axsome Therapeutics, Inc.3$63
E.R. Squibb & Sons, L.L.C.2$41
Janssen Pharmaceuticals, Inc1$29
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$27

Products named: ARISTADA, REXULTI, VRAYLAR, SUBLOCADE, AUSTEDO XR, UZEDY, BRIXADI, Auvelity.

Industry payments across MI — which companies pay providers there.